Effects of Non-calorie Sweeteners, Mono- and Disaccharides on Intestinal Barrier Function
NCT ID: NCT04788680
Last Updated: 2023-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2021-03-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota
NCT02580110
Effects of Artificial Sweeteners on Gut Microbiota and Glucose Metabolism
NCT02569762
Effect of the Natural Sweeteners Erythritol and Xylitol on Gut Microbiota and Glucose Metabolism in Obese Volunteers
NCT02824614
Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome
NCT03259685
Impact of Sweeteners on Behaviour, Physiology & Health
NCT04633681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: Beverage 1
Participants receive a beverage with a defined amount of non-nutritive sweetener.
Dietary intervention 1
Participants receive a beverage with a defined amount of non-nutritive sweetener.
Experimental: Beverage 2
Participants receive a beverage with a defined amount of non-nutritive sweetener.
Dietary Intervention 2
Participants receive a beverage with a defined amount of non-nutritive sweetener and maltodextrin.
Experimental: Beverage 3
Participants receive a beverage with a defined amount of monosaccharide.
Dietary Intervention 3
Participants receive a beverage with a defined amount of monosaccharide.
Experimental: Beverage 4
Participants receive a beverage with a defined amount of disaccharide.
Dietary Intervention 4
Participants receive a beverage with a defined amount of disaccharide.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary intervention 1
Participants receive a beverage with a defined amount of non-nutritive sweetener.
Dietary Intervention 2
Participants receive a beverage with a defined amount of non-nutritive sweetener and maltodextrin.
Dietary Intervention 3
Participants receive a beverage with a defined amount of monosaccharide.
Dietary Intervention 4
Participants receive a beverage with a defined amount of disaccharide.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \<25 kg/m2
Exclusion Criteria
* Chronic disease of the gastrointestinal tract
* Renal insufficiency
* Taking drugs affecting lipid or glucose metabolism
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Ina Bergheim
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UVienna21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.